- Home
- RWAY vs AMLX Comparison
RWAY vs AMLX Comparison
Compare RWAY & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWAY
- AMLX
- Stock Information
- Founded
- RWAY 2015
- AMLX 2014
- Country
- RWAY United States
- AMLX United States
- Employees
- RWAY N/A
- AMLX N/A
- Industry
- RWAY
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- RWAY
- AMLX Health Care
- Exchange
- RWAY Nasdaq
- AMLX Nasdaq
- Market Cap
- RWAY 395.5M
- AMLX 459.1M
- IPO Year
- RWAY 2021
- AMLX 2022
- Fundamental
- Price
- RWAY $9.93
- AMLX $5.15
- Analyst Decision
- RWAY Buy
- AMLX Buy
- Analyst Count
- RWAY 6
- AMLX 5
- Target Price
- RWAY $10.75
- AMLX $9.80
- AVG Volume (30 Days)
- RWAY 344.4K
- AMLX 1.1M
- Earning Date
- RWAY 05-12-2025
- AMLX 05-08-2025
- Dividend Yield
- RWAY 12.09%
- AMLX N/A
- EPS Growth
- RWAY 51.80
- AMLX N/A
- EPS
- RWAY 1.67
- AMLX N/A
- Revenue
- RWAY $140,021,000.00
- AMLX N/A
- Revenue This Year
- RWAY N/A
- AMLX N/A
- Revenue Next Year
- RWAY N/A
- AMLX N/A
- P/E Ratio
- RWAY $5.96
- AMLX N/A
- Revenue Growth
- RWAY N/A
- AMLX N/A
- 52 Week Low
- RWAY $8.35
- AMLX $1.58
- 52 Week High
- RWAY $12.17
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- RWAY 57.59
- AMLX 56.51
- Support Level
- RWAY $9.65
- AMLX $4.64
- Resistance Level
- RWAY $9.95
- AMLX $5.40
- Average True Range (ATR)
- RWAY 0.23
- AMLX 0.39
- MACD
- RWAY 0.04
- AMLX -0.04
- Stochastic Oscillator
- RWAY 65.26
- AMLX 70.37
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.